Scientists Solve the Crystal Structure of the Psilocbyin Derviative 4-HO-DPT
This new crystal form presents new options for developing psychedelics into therapeutic drug formulations.
Articles - Page 2
Why Are Crystal Structures Important in Psychedelic Research?
Crystal structures help researchers understand changes at the molecular level that affect the physical properties of compounds.
Say Hello to World’s First Psychedelic Microdosing Study Mobile App
Contribute to the understanding of microdosing by participating in this study using your mobile device.
Paul Stamets Tells Joe Rogan About the Future of Psilocybin Research
Stamets says standardized formulations of multiple psilocybin analogs are the "wave of the future" because of the entourage effect.
5 Fast Facts About Magic Mushroom Compounds
There’s a lot more going on inside magic mushrooms than just psilocybin.
New Psilocybin Microdosing Data: How Much is Too Much?
Real-time gathering of physiological data and subjective effects give clues that may help define a microdose of psilocybin.
Female Hormones, 5-HT2A Receptors, and Psychedelics
Female hormones affect binding at the 5-HT2A receptor. Does this mean there is a uniquely female entourage effect with psychedelics?
The Serotonin Receptors: Comparing the Binding Affinity of 5 Psychedelics
Looking at the data side by side reveals there is much work to do, and why understanding the entourage effect is essential.
“Magic Mushroom” Microdosing Nasal Spray Announced
Nasal spray formulations could offer precision dosing of a spectrum of psychedelic mushroom compounds to consumers
Usona Follows COMPASS in Receiving Breakthrough Therapy Designation for Psilocybin to Treat Depression
This means the FDA will work to expedite the development and review of psilocybin so it can get to patients with major depressive disorder as soon as possible.